Biotrace Medical

Developer of cardiac pacing device to treat reversible symptomatic bradycardia

placeSan Carlos, California, United States calendar_todayFounded 2013 groups16 employees language biotracemedical.com

Registered entities

Innovation

3 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 393 times.

YearFilings
20152
20161
20171
20182
20191
20201
20212
20221

Investor mix

3 investors on record; lead investors include Xandex Investments.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon